Q: Is the recent pull back in Biosyent a good buying opportunity? What do you think of the company? I have been interested in RX due to their very consistent track record, good balance sheet, and free cash flow generation but the stock was always a bit "pricey". Thanks.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: I’m down 30% on Grande West in my TFSA and am willing to hold if there are reasonable prospects for recovery in the near term. Given the recent volatility in markets I’m finding I’m reluctant to hold riskier stocks for the long term on the hope of a recovery. What is your outlook for this company?
Q: What do you think of JTR financial results just released today?
Q: Morning,2/13,BUS announced that Landry,VP,Sales becomes CEO replacing existing CEO Trainer,who becomes President & Director.Price was $1.96 on 2/12 but now $1.83(2/14).Have 1/2 position @ $2.03.Please may I have your opinion on the above change & should I continue to hold the shares.Thanks for u usual great services & views.
-
DHX Media Ltd. Common and Variable Voting Shares (DHX)
-
D-Box Technologies Inc. Class A Common Shares (DBO $0.63)
Q: I would appreciate your comments on DBO & DHX.B which reported recently. Both appeared to do well . Should I get rid of them or hold on for a turn around based on their recent reports? Thanks as always for your great service.
Dave
Dave
Q: in your opinion is this sell off in covalon overdone or is it justified.dave
Q: Ticker OSS.V, please give your assessment of this company.
Q: This stock had an upgrade today.Do you have any thoughts on this small cap.Thanks
Q: Would you comment on Andrew Peller's recent results and give your outlook for it in the future, please?
Q: What are your thoughts on this company going forward? Thanks
Q: Hi,
Covalon is down 19% today after the earnings release. Do you still consider this company a buy and if so would this be a good opportunity to get in.
Covalon is down 19% today after the earnings release. Do you still consider this company a buy and if so would this be a good opportunity to get in.
Q: Your thoughts on their last quarter release ?
Q: HI Team,
Just wanted to put ESP on the radar once again.. on Feb 7 they announced a deal with a television provider that has a million+ subscribers. This new contract along with EastLink and the other smaller contract wins, have not yet been adequately reflected in the share price. Penderfund owns 15% of the company. Year end numbers could still be weak, but I think the Outlook is fairly positive given the recent wins. Your updated comments are appreciated.
Cheers,
Just wanted to put ESP on the radar once again.. on Feb 7 they announced a deal with a television provider that has a million+ subscribers. This new contract along with EastLink and the other smaller contract wins, have not yet been adequately reflected in the share price. Penderfund owns 15% of the company. Year end numbers could still be weak, but I think the Outlook is fairly positive given the recent wins. Your updated comments are appreciated.
Cheers,
Q: Espial is actually up in this market. Winning new contracts. Have been researching it for awhile but now I am thinking it is time to buy. Your views please. Thanks.
Q: Would Amazon's announcement of doing their own shipping affect CJT here in Canada, or would our market be too small for them to enter?
Q: Hi, could you please comment on the earning release, this morning. Thanks
Q: Was wondering if 5i attended the recent Cantech Investment Conference? If yes, are there any up and coming companies or tech trends we should be keeping an eye on?
Thanks
Sal
Thanks
Sal
Q: In view of recent earnings report, do you see any potential to justify holding Firan? (2% position) I have about 2.5% positions in both PHO and OTEX . Should I dump FTG to top up either or both of the other two??
Q: Hi Peter:
Would appreciate your thoughts on Kraken Sonar, small cap company with interesting technology. The made a small profit in Q3 but their history is more of an R&D business. Do you see greater revenue growth in the coming quarters with their product lines?
Thanks for your great service, have found your site to be very helpful in earning above market returns.
Regards
Victor
Would appreciate your thoughts on Kraken Sonar, small cap company with interesting technology. The made a small profit in Q3 but their history is more of an R&D business. Do you see greater revenue growth in the coming quarters with their product lines?
Thanks for your great service, have found your site to be very helpful in earning above market returns.
Regards
Victor
Q: You answered a question on QST saying it does not have analysts following the name, so no estimates exist. In fact Acumen Capital covers QST with a Buy $4.85 -12 month target.